研究

参与研究

美利坚合众国劳伦

“Will this (research) help?”

Sandra Bartolomeu Pires, Nurse Researcher 

A few months ago, I was trying to find people interested in participating in my research project called Integrate-HD, and a member of the Huntington’s Disease community asked me “Will this help?”. Now, my research does not involve testing a new drug, it does not involve testing novel equipment, heck, I am not testing absolutely anything! Will my research help?!

You see, the problem I am trying to solve is the lack of care access and the lack of care coordination that people with Huntington’s Disease experience. I do not have to explain the reality of these problems to you, as you will know them better than me. I am not personally affected by HD, in fact, I only had my first patient with HD 10 years ago. But HD has been glued to me since then, and, for varied reasons, I always felt HD was treated like the underdog. My mum always told me I always pick the hardest path, and so here you find me, researching how to improve care with the HD community.

I started by looking at activities that had been tested that could improve care coordination in HD, but unfortunately there was none to be found. And so, I started designing those activities with the HD community, through research. First, I wanted to know how bad the situation was were I lived, in England (pretty bad), then I asked people what good care looked like through individual interviews and group discussions (results undergoing publication). And this short paragraph has taken 5 years of my life, even without any testing…

Now, for me, the testing is the next phase. I daydream that I can develop an effective intervention that can support people better and at no added cost, perhaps even cheaper to the government in the long run! If I manage to convince the people who take the decisions to reorganize care, perhaps, in time, my research will help people. You may have heard this, but research takes approximately 17 years from theory to practice. Good thing I am only 37 and I am prone to the hardest paths.

I have found people very disheartened with the system, exhausted by all the obstacles of life, too sick to take part in any research, or just wanting a break from HD related stuff. Participating in research can be very demanding. But, if you find the will, the time, the energy, join research: as a participant, as an advocate contributor, or by sharing a post you found interesting. I remain hopeful that together with the community, we can make a difference. Regardless of the time it takes us, we will keep pushing for better care and better treatment.

“The best time to start anything was yesterday. The 2nd best time to do it, is always today”.

You can find research opportunities, for testing interventions and/or for building knowledge, on many websites, for example 这里. You can also contact your local HD association and The International Huntington Association

Blog written by Sandra Bartolomeu Pires, expanding on her Instagram post  @integrate_hd dated 22nd October 2024. Sandra is a nurse researcher passionate in improving care for people living with Huntington’s Disease. She is writing her doctoral thesis and is not currently recruiting to any study.

了解合作在药物研发中的价值

Seth Rotberg,Prilenia 患者宣传部 

您是否想过,在药物开发过程中,企业、患者团体和患者社区之间的合作关系的真正价值是什么?作为一个在人生的不同阶段都参与过这一领域的人,我可以亲身告诉你--这是一件非常重要的事情。如果我们真的想推进临床研究,患者团体和社区必须参与到药物开发的各个阶段。

我的患者维权之路始于 15 岁,当时我第一次得知妈妈被诊断出患有亨廷顿氏病(HD),而在这之前的 5-7 年里,她一直被误诊。医生最初诊断她患有重度抑郁症和情绪波动,而邻居们则认为她白天酗酒,因为她的平衡感很差,行动摇摆不定。所有这些迹象最终都成为了 HD 的症状。

我花了几年时间来适应这种新常态,然后决定参与社区活动,举办筹款活动,提高人们对 HD 的认识。最终,我在患者团体中担任了不同的领导职务,帮助支持 HD 社区未得到满足的需求。有一次,我甚至成立了一个患者组织,专门为患有罕见病和慢性病的年轻人提供支持。

时至今日,我有幸为一家从事 HD 研究的小型生物技术公司监督患者宣传和参与工作。以下是我的心得体会:

1.患者群体和患者社区成员在药物研发中发挥着至关重要的作用。他们拥有亲身经历,对疾病的理解是教科书或实验室无法提供的。

2.通过分享他们与生物技术和制药公司合作的经历,患者可以帮助塑造正在进行的研究,包括哪些疾病会受到关注、哪些终点会在试验中被研究,以及从患者的角度来看成功是什么样的。反馈可以通过向公司员工提供客座演讲机会、临床试验设计、教育材料、如何宣传参与临床试验等多种机会实现!

患者的意见在药物研发从发现到批准后的每一个阶段都很重要:帮助研究人员了解疾病,为临床试验的设计和招募策略出谋划策,在疗法获得批准后为其提供支持,以及分享使用已获批准疗法的经验。

要使合作取得成功,患者群体和社区成员就必须参与进来,提出问题或举手发言,帮助推动研究。就公司对疾病的了解及其工作状况向公司提出质疑。推动创新当然需要全村的努力,尤其是在罕见病领域。更重要的是 没有治疗方法的疾病。对于那些已经参与其中一些机会的人来说,感谢你们继续倡导帮助改变药物开发的现状!

塞斯-罗特伯格是全国知名的患者领袖、医疗保健行业专业人士和 TEDx 演讲者。在他的母亲与亨廷顿氏症(Huntington's Disease,HD)进行了长达 17 年的斗争之后,赛斯将改善患者的医疗体验作为自己的使命。他目前负责 Prilenia 的患者宣传和参与工作,本文中的观点仅代表 Prilenia 员工的观点。

请注意,这位客人 博文由 Prilenia 赞助。

zh_CNChinese